Skip Navigation


Hum. Reprod. Advance Access originally published online on March 2, 2007
Human Reproduction 2007 22(6):1578-1584; doi:10.1093/humrep/dem034
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/6/1578    most recent
dem034v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gainer, E.
Right arrow Articles by Bouyer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gainer, E.
Right arrow Articles by Bouyer, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception

E. Gainer1,2,4, R. Massai3, S. Lillo3, V. Reyes3, M.L. Forcelledo3, R. Caviedes3, C. Villarroel3 and J. Bouyer2

1 Laboratoire HRA Pharma, Paris, France 2 Institut National de la Santé et de la Recherche Médicale, U569 Epidemiology, Demography and Social Sciences, Le Kremlin-Bicêtre, France; Institut National d'Etudes Démographiques, Paris, France; Université Paris-Sud, Faculté de Médecine, IFR69, Le Kremlin-Bicêtre, France 3 Instituto Chileno de Medicina Reproductiva, ICMER José Victorino Lastarria 29, Depto 101, Santiago, Chile

4 To whom correspondence should be addressed at: Laboratoire HRA Pharma, Paris 75003, France, E-mail: e.gainer{at}hra-pharma.com

BACKGROUND: Progestin-only methods are among the contraceptive options available for breastfeeding women, however the doses of progestin used in emergency contraception (EC) have not been evaluated in nursing mothers. We therefore investigated the pharmacokinetics of 1.5 mg levonorgestrel (LNG) in lactating women.

METHODS: Twelve healthy exclusively breastfeeding volunteers received 1.5 mg LNG. Women refrained from nursing for 72 h after dosing and fed their infants with milk frozen beforehand. Serial blood and milk samples were collected for 120 h and assayed for LNG and sex hormone binding globulin.

RESULTS: LNG concentrations peaked in plasma and in milk 1–4 h and 2–4 h after dosing, respectively. Concentrations in milk (M) paralleled those in plasma (P) but were consistently lower (mean M:P ratio 0.28). Estimated infant exposure to LNG is 1.6 µg on the day of dosing (1 µg in the first 8 h), 0.3 µg on the second day and 0.2 µg on the third day.

CONCLUSIONS: Nursing mothers may need EC. These results suggest that to limit infant exposure to the period of maximum LNG excretion in milk, mothers should discontinue nursing for at least 8 h, but not more than 24 h, after EC.

Key words: breastfeeding/emergency contraception/lactation/levonorgestrel/pharmacokinetics

Submitted on November 6, 2006; resubmitted on January 18, 2007; accepted on January 22, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EndocrinologyHome page
C. K. Wagner
Progesterone Receptors and Neural Development: A Gap between Bench and Bedside?
Endocrinology, June 1, 2008; 149(6): 2743 - 2749.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.